COVID-19肺炎对间质性肺疾病的影响:CT半定量评估
该回顾性研究纳入102例间质性肺疾病(ILD)患者,其中48例有COVID-19肺炎史,54例无。所有患者均有基线和随访CT,半定量评估显示COVID-19组总CT评分增加4.5±4.6分,对照组增加1.2±2.7分(p<0.001);IPF亚组中COVID-19组增加7.0分(95%CI 4.1-9.9),对照组增加2.1分(95%CI 0.8-3.4)。COVID-19组7例(14.6%)纤维化模式进展,对照组无进展。
要点
- COVID-19肺炎可加速ILD患者CT评分进展,IPF亚组更明显。
- COVID-19组部分患者纤维化模式恶化,对照组无变化。
- 随访CT半定量评估有助于监测ILD合并COVID-19后的进展。
关键影像表现/征象
- COVID-19组总CT评分平均增加4.5±4.6分,对照组增加1.2±2.7分(p<0.001)。
- IPF亚组中,COVID-19组总CT评分增加7.0分(95%CI 4.1-9.9),对照组增加2.1分(95%CI 0.8-3.4)。
- COVID-19组7例(14.6%)纤维化模式进展至更高分级,对照组无进展。
临床应用与阅片要点
- 对ILD患者,尤其IPF,感染COVID-19后应关注随访CT上半定量评分变化。
- 阅片时注意纤维化模式是否进展,如网格影、牵拉性支气管扩张等。
局限性
- 回顾性研究设计。
- 样本量有限,仅纳入IPF和CTD-ILD患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the CT scores and fibrotic pattern changes in interstitial lung disease (ILD) patients, with and without previous COVID-19 pneumonia.
METHODS: Patients with ILD (idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated ILD (CTD-ILD)) were retrospectively enrolled in the study which consisted of patients who had COVID-19 pneumonia while the control group had not. All patients had two CT scans, initial and follow-up, which were evaluated semi-quantitatively for severity, extent, and total CT scores, fibrosis patterns, and traction bronchiectasis.
RESULTS: A total of 102 patients (pneumonia group n = 48; control group n = 54) were enrolled in the study. For both groups, baseline characteristics were similar and CT scores were increased. While there was a 4.5 ± 4.6 point change in the total CT score of the COVID-19 group, there was a 1.2 ± 2.7 point change in the control group (p < 0.001). In the IPF subgroup, the change in total CT score was 7.0 points (95% CI: 4.1 to 9.9) in the COVID-19 group and 2.1 points (95% CI: 0.8 to 3.4) in the control group. Seven patients (14.6%) in the COVID-19 group progressed to a higher fibrosis pattern, but none in the control group.
CONCLUSIONS: Semi-quantitative chest CT scores in ILD patients demonstrated a significant increase after having COVID-19 pneumonia compared to ILD patients who had not had COVID-19 pneumonia. The increase in CT scores was more prominent in the IPF subgroup. There was also a worsening in the fibrosis pattern in the COVID-19 group.
KEY POINTS: • The impact of COVID-19 pneumonia on existing interstitial lung diseases and fibrosis is unclear. • COVID-19 pneumonia may worsen existing interstitial lung involvement with direct lung damage and indirect inflammatory effect. • COVID-19 pneumonia may affect existing lung fibrosis by triggering inflammatory pathways.
引用
- Doğan, Güldiken, Alpaslan, et al. Impact of COVID-19 pneumonia on interstitial lung disease: semi-quantitative evaluation with computed tomography. Eur Radiol. 2023. PMID: 36764951. doi:10.1007/s00330-023-09441-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。